ライフサイエンスコーパス: laboratory data

1 ing, insufficient, or early or late baseline laboratory data.

2 ts that are readily obtainable from clinical laboratory data.

3 ion efficiency was found from both field and laboratory data.

4 re based primarily on extensive experimental laboratory data.

5 wed that the results are consistent with the laboratory data.

6 f RNA-Seq was compared to available clinical laboratory data.

7 ved loose bowels and skin lesions as well as laboratory data.

8 hospitalization, treatment tolerability, and laboratory data.

9 ic findings in combination with clinical and laboratory data.

10 Clinical and laboratory data.

11 rtant data that significantly complement the laboratory data.

12 -care testing (POCT) is rapid acquisition of laboratory data.

13 determined the cause of death and collected laboratory data.

14 endotherm that accurately predicts field and laboratory data.

15 stantial structural problems and issues with laboratory data.

16 at least 2 orders of magnitude over previous laboratory data.

17 ly 78% of available electronic health record laboratory data.

18 xplained by adverse events, microbiology, or laboratory data.

19 th baseline BNP levels and angiographic core laboratory data.

20 stribution of parameters consistent with the laboratory data.

21 can be attained from inverting the tailored laboratory data.

22 rrelate this with clinical, morphologic, and laboratory data.

23 immunosuppressive therapies and experimental laboratory data.

24 ere identified using cardiac catheterization laboratory data.

25 lts can be directly correlated with clinical laboratory data.

26 rvice use records, physical examination, and laboratory data.

27 y involved in the ordering of vital signs or laboratory data.

28 show credible results when compared against laboratory data.

29 opsy, and with a combination of clinical and laboratory data.

30 etreatment measures included demographic and laboratory data.

31 III scores were calculated from clinical and laboratory data.

32 eries analysis was performed on microbiology laboratory data.

33 ge and is complicated by a lack of field and laboratory data.

34 lent diagnoses of lung cancer, or incomplete laboratory data.

35 ed the acquisition of extensive clinical and laboratory data.

36 ing demographic, clinical, instrumental, and laboratory data.

37 mographic, clinical, neurophysiological, and laboratory data.

38 mographic, clinical, neurophysiological, and laboratory data.

39 ine reference, and patient-specific (weight, laboratory) data.

40 measured NT-proBNP data (c-indices: 0.80 [w/laboratory data]-0.81 [full model]); net reclassificatio

41 identified comorbidities using pretransplant laboratory data, (2) investigate additional HCT-related

42 s-sectional analysis of survey and automated laboratory data 2969 primary care diabetic patients of a

43 tissue specimens and associated clinical and laboratory data; (3) develop standards for the classific

44 440 girls with both reproductive health and laboratory data, after accounting for BMI and race/ethni

45 If fatty liver was identified, then laboratory data and a liver biopsy were obtained.

46 Sepsis-related Organ Failure Assessment, and laboratory data and biomarkers of organ injury.

47 ified AKI events not requiring dialysis from laboratory data and classified them according to the rat

48 Previous and current therapy, laboratory data and clinical activity were recorded at t

49 However, there are now considerable laboratory data and clinical experience demonstrating sa

50 the type of colitis is based on clinical and laboratory data and colonoscopic and biopsy findings, bu

51 > A and 187C-->G HFE mutations, and analysed laboratory data and data on signs and symptoms of haemoc

52 tation must be tested using a combination of laboratory data and evidence about cooperation "in the w

53 ons used different combinations of basic and laboratory data and had SEEs of 1.55 and 1.65 MJ/d, resp

54 sing on the utility of physical examination, laboratory data and imaging (both ultrasonography and co

55 association between patient demographics or laboratory data and IOPTH half-life.

56 Laboratory data and outside medical records help identif

57 Laboratory data and radiographic response were measured

58 ing findings were compared with clinical and laboratory data and radiographic results.

59 cal history responses were compared with the laboratory data and several abnormalities were noted.

60 The clinical and laboratory data and the findings of the initial US and M

61 hallenge hypotheses derived from clinical or laboratory data and to suggest further directions for in

62 orbid disease, physiology at admission (from laboratory data), and transfer status.

63 We studied the demographics, presenting laboratory data, and clinical course of 627 consecutivel

64 Demographic information, laboratory data, and diagnoses were extracted from the c

65 n, quality of life, adverse events, clinical laboratory data, and electrocardiogram results were asse

66 for patient diagnoses within the past year, laboratory data, and for clustering of patients within h

67 Presentation, clinical course, laboratory data, and histopathological evidence of ische

68 nt's clinical history, physical examination, laboratory data, and imaging.

69 Demographic information, laboratory data, and medication exposure were extracted

70 rs for acute kidney disease, physiologic and laboratory data, and outcomes were recorded.

71 ional electronic tuberculosis register data, laboratory data, and published studies.

72 CDI is a clinical diagnosis supported by laboratory data, and the detection of toxigenic C. diffi

73 ata, physical examination findings, or basic laboratory data; and (3) confirmed or excluded appendici

74 Screening laboratory data appears to be less sensitive to detect t

75 We parameterised the model with laboratory data, applied it to predict survival in the f

76 Limited clinical and laboratory data are available on patients with Ebola vir

77 if all the test-negative cases with missing laboratory data are EV71-HFMD.

78 Epidemiological and laboratory data are scarce among Andean and Mexico, Cent

79 Demographic, anthropometrical, and laboratory data, as well as family history of type 2 DM

80 Demographic, anthropometrical, and laboratory data, as well as immunosuppressive and antihy

81 th study groups were matched in clinical and laboratory data, as well as volume of injected contrast.

82 demographic factors, behavioral factors, and laboratory data associated with the metabolic syndrome.

83 s, and immediate postoperative and follow-up laboratory data at 1 month are indicative of a cure.

84 ria for Adverse Events (version 3.0) for all laboratory data at regular follow-up visits and during o

85 ion was often related to missing clinical or laboratory data at the MDPH as well as restrictive defin

86 pretransplant information including routine laboratory data available before or at the time of trans

87 ing the implementation of local and national laboratory data-based surveillance systems for the routi

88 oncology combining anatomical, metabolic and laboratory data can be designed.

89 This study investigates if laboratory data can be used to assess whether physician-

90 More generally we illustrate how clinical laboratory data can be used to develop and to test a dyn

91 a combination of histological, clinical, and laboratory data can be used to stage CR.

92 no-scrotal sonography, supported by relevant laboratory data can clinch the accurate diagnosis.

93 of ADM with POA codes and readily available laboratory data can efficiently support accurate risk-st

94 ing present on admission codes and numerical laboratory data collected at the time of admission resul

95 Laboratory data confirmed that clinical responses correl

96 riceal bleed, encephalopathy or ascites, and laboratory data did not influence accuracy of CT volumet

97 tive clinical data (clinical manifestations, laboratory data, disease activity, damage, and mortality

98 Direct observation of verbalized laboratory data during daily ICU rounds compared with da

99 Epidemiologic and laboratory data each generated large and dense networks.

100 In addition to clinical and laboratory data, electrocardiograms (EKGs), chest radiog

101 Unfortunately, there are no basic laboratory data examining 8-OHdG levels in animal models

102 Clinical and laboratory data, food records, and activity logs were co

103 We collected clinical and laboratory data for 410 patients from Oxford city hospit

104 We retrospectively reviewed radiographic and laboratory data for all patients from a single center wh

105 ysical examination, serum, or synovial fluid laboratory data for diagnosing septic arthritis.

106 However, the lack of laboratory data for Earth's most abundant mineral, (Mg,F

107 We analyzed demographic, clinical, and laboratory data for newly diagnosed pediatric (age <15 y

108 Epidemiologic, clinical, and laboratory data for outbreak cases residing in NYC were

109 The clinical and laboratory data for patients with positive cultures were

110 We compiled clinical and laboratory data from 11 patients with hematological mali

111 Anonymized samples and laboratory data from 1491 African-American and 31 005 wh

112 tion models using demographic, clinical, and laboratory data from 2 independent Canadian cohorts of p

113 Clinical and laboratory data from 4,445 patients with NDMM enrolled o

114 database, which contains administrative and laboratory data from 6 pediatric hospitals in the United

115 tal CMV infection, we extracted clinical and laboratory data from 7 days before until 7 days after in

116 sign, we examined clinical, histological and laboratory data from 749 consecutive unselected CD child

117 Clinical and laboratory data from 80 untreated children with juvenile

118 011, we prospectively collected clinical and laboratory data from all patients with Buruli ulcer diag

119 We extracted epidemiological, clinical, and laboratory data from cases of hand, foot, and mouth dise

120 Clinical and laboratory data from coeliac patients who later develope

121 We use both laboratory data from cytometry experiments as well as da

122 Clinical and laboratory data from each patient's hospital records wer

123 cted BMR, body-composition, demographic, and laboratory data from electronic databases of 757 volunte

124 A neural network score with laboratory data from hospital-day 7 improved prognostic

125 In a retrospective analysis of laboratory data from Oxford University Hospitals Nationa

126 assessment focused on detailed clinical and laboratory data from patients with suspected DILI.

127 a single laboratory validation data or inter-laboratory data from Proficiency Testing schemes.

128 or cyclosporine (CyA) toxicity, clinical and laboratory data from the day of the biopsy were reviewed

129 Purpura (UK TTP) Registry with clinical and laboratory data from the largest cohort of pregnancy-ass

130 We combined laboratory data from the National Health and Nutrition E

131 ned retrospective demographic, clinical, and laboratory data from the period 2003-2007 for children h

132 ly assigned from ranges defined by field and laboratory data, generated an emergent community structu

133 ty of supplementing administrative data with laboratory data has not been assessed.

134 Recent laboratory data have clarified a number of key mechanist

135 Laboratory data have suggested that sequential treatment

136 A comparison of the model with empirical laboratory data illustrates that most experimentally obs

137 ith multidimensional phenotypes that include laboratory data, images, vital signs, and other clinical

138 All notes, laboratory data, imaging results, other diagnostic studi

139 rt study of Medicare beneficiaries linked to laboratory data in 10 states with prevalent heart failur

140 ico predictions were validated by subsequent laboratory data in NOD mice with T1D that received anti-

141 was performed for all available clinical and laboratory data in patients with biopsy-confirmed NSF.

142 inty in the risk of EV71-HFMD due to missing laboratory data in the national database, (ii) excluding

143 Clinical and laboratory data including serial Expanded Disability Sta

144 We collected various laboratory data including serum creatinine, calcium, pho

145 Laboratory data including total and specific IgE were ev

146 gate the ability of patient characteristics, laboratory data (including MELD scores), and hemodynamic

147 Clinical and laboratory data, including 62.3+/-26.1 months follow-up

148 Demographic, clinical, and laboratory data, including measures of 11 antibodies, we

149 Clinical and laboratory data, including tests for HCV and urinary por

150 Laboratory data indicate that morphine decreases the num

151 emained stable over the study period, and no laboratory data indicated liver or kidney injury or dysf

152 a was melded with demographic, clinical, and laboratory data into a database on an ongoing basis usin

153 Computer spreadsheet modeling results and laboratory data involving 16 pairs of analyte and intern

154 substituting clinical surrogates for missing laboratory data is an appropriate alternative to the con

155 model), POA-ADM supplemented with admission laboratory data (Laboratory model), Laboratory model sup

156 models), restricted administrative data plus laboratory data (laboratory models), and restricted admi

157 Pred to an additional seven isolates with no laboratory data led to types that clustered with identic

158 aphics, location of evaluation, clinical and laboratory data, major organ system dysfunction, 48-hr p

159 egrate their results with other clinical and laboratory data may lead to incorrect patient management

160 PheWAS of EMR data, with linkage to laboratory data obtained from blood samples, provide a n

161 ive factors, postoperative hemodynamics, and laboratory data obtained on admission and during the ICU

162 Consequently, laboratory data obtained on olivine separates might yiel

163 The clinical and laboratory data of 100 consecutive patients with repaire

164 pecies level in clinical samples may provide laboratory data of crucial importance in epidemiologic i

165 infection were reviewed retrospectively for laboratory data of hepatic parenchymal inflammation and

166 This was a review of clinical and laboratory data of men and women presenting to the Jeffe

167 ospective cohort study, we used clinical and laboratory data of patients who had haemopoietic cell tr

168 The association between laboratory data of patients with decreased DLCO or restr

169 The clinical presentation and laboratory data of the index patient were typical of mea

170 Adding laboratory data (often available electronically) to rest

171 Laboratory data on 4,735 Neisseria meningitidis strains

172 r (DLC) exposures, we extrapolated published laboratory data on common terns to roseate terns by char

173 tract clinical, hemodynamic, medication, and laboratory data on patients admitted to the LTICU from M

174 del predictions are tested against available laboratory data on petroleum liquid densities, gas/liqui

175 Patient demographics, pre-OLT laboratory data, operative data, and early and late post

176 , without knowledge of clinical information, laboratory data, or previous biopsy interpretation.

177 tus for each veteran was identified from HBV laboratory data performed prior to DAA initiation.

178 f MAG3 renal studies were also compared with laboratory data pertaining to creatinine clearance in al

179 cidin-25 level, and relevant demographic and laboratory data pertinent to posttransplantation anemia,

180 Missing clinical and laboratory data precluded evaluation of some reports.

181 oring system based on objective clinical and laboratory data provides meaningful risk stratification

182 NNDSS HCV case reports and Quest laboratory data regarding unique reproductive-aged women

183 r AVB and correlated with clinical symptoms, laboratory data, rejection grade, and echocardiogram and

184 t sign on physical examination and screening laboratory data remains controversial, although screenin

185 performed for a subset of patients with all laboratory data required to analyze the data via physica

186 ablished electronic health record, clinician laboratory data retrieval and communication during ICU r

187 In addition, recent laboratory data reveal glutamine may act via mechanisms

188 Laboratory data revealed proteinuria and severe depletio

189 Among subjects with available laboratory data, scores on the Framingham Cardiovascular

190 outside predefined CLSI criteria, the entire laboratory data set was excluded.

191 criteria resulted in exclusion of the entire laboratory data set.

192 Moreover, the incorporation of the actual laboratory data sets into the analysis phase offers a po

193 Neural networks using clinical and laboratory data showed a high prognostic accuracy for pr

194 Clinical laboratory data shows that most results are within the r

195 Both clinical and laboratory data stress the vast potential of tumor vacci

196 Additional epidemiologic and recent laboratory data strongly support the UK government's con

197 Clinical and laboratory data sufficient to calculate Mortality in Eme

198 Recent laboratory data suggest a role for BRCA1/2 in the cellul

199 Laboratory data suggest that As(2)O(3) induces apoptosis

200 Epidemiologic, clinical, and laboratory data suggest that H5N1 influenza viruses are

201 Laboratory data suggest that harmful epinephrine-induced

202 Clinical experience and laboratory data suggest that human cytomegalovirus (HCMV

203 Laboratory data suggest that intake of vitamin A and car

204 Recent clinical and laboratory data suggest that repair of treatment-related

205 Laboratory data suggest that the role of dopamine in mig

206 Laboratory data suggested that bicarbonate enhanced the

207 ntaneous macromolecular damage inferred from laboratory data, suggesting that microbes imprisoned in

208 ting for patient demographics, case-mix, and laboratory data, suggesting the involvement of other fac

209 fish production, and all published field and laboratory data support the conclusion that something ot

210 Observational and recent laboratory data support the need for randomized clinical

211 Information obtained included demographics, laboratory data, symptoms, operative procedure (includin

212 transferase levels were the only clinical or laboratory data that independently predicted severity of

213 These conclusions are supported by laboratory data that subsequently identified three addit

214 Because of laboratory data that suggests improved metabolism of AMT

215 intensive care unit patient stays, including laboratory data, therapeutic intervention profiles such

216 ing present on admission codes and numerical laboratory data to administrative claims data.

217 and accuracy of clinical, radiographic, and laboratory data to diagnose bacterial VAP relative to a

218 memory B cells, while gathering longitudinal laboratory data to examine the progressive nature of the

219 truct one simple model consisting of routine laboratory data to predict both significant fibrosis and

220 measured and readily available clinical and laboratory data to separate NAFLD patients with and with

221 We discuss the potential for scaling these laboratory data to three-dimensional canopy space.

222 ew approaches to analyzing epidemiologic and laboratory data to understand transmission during this o

223 eclassification index improved from 0.035 (w/laboratory data) to 0.085 (complete model).

224 inside village kitchens, in conjunction with laboratory data, to assess the health impacts of new coo

225 importance of considering epidemiologic and laboratory data together when evaluating potential etiol

226 regimens, ammonia levels and other pertinent laboratory data, treatments administered, and outcomes w

227 ure compares model predicted values with the laboratory data via the standard Bayesian techniques wit

228 ed with admission vital signs and additional laboratory data (VS model), VS model supplemented with k

229 A multivariable model using routine laboratory data was able to predict advanced chronic kid

230 Detailed clinical and laboratory data was collected from the centers concerned

231 None of the clinical and laboratory data was useful in distinguishing ACR from Cy

232 On the basis of a synthesis of clinical and laboratory data, we developed a biological functions cla

233 Using commercial laboratory data, we found 80% of 29382 young persons cur

234 ng Taylor's Power Law to integrate field and laboratory data, we found that only treatments involving

235 he endoscopic reports, clinical records, and laboratory data were also reviewed and compared with the

236 Clinical and laboratory data were also used to assess the value of HD

237 Clinical and laboratory data were analyzed for correlates of response

238 Demographic and laboratory data were analyzed in participants (n = 4814,

239 m within 24 hours of the visit, and abnormal laboratory data were available for review within a media

240 Laboratory data were collected at baseline and 1 mo afte

241 Demographic, physiologic, and laboratory data were collected before initiation, 2 hrs

242 Clinical and laboratory data were collected for 323 adults with radio

243 Demographic, physiological, and laboratory data were collected for as long as NPPV was p

244 Clinical and laboratory data were collected from each subject.

245 Demographic, hemodynamic, and laboratory data were collected in all ICU patients who w

246 Initial clinical and laboratory data were collected in the emergency departme

247 in MRI, cardiac MRI, neuropsychological, and laboratory data were collected on 1504 Framingham Offspr

248 utcomes and Measures: Extensive clinical and laboratory data were collected on patients who were subc

249 Clinical and laboratory data were collected retrospectively.

250 Epidemiological, clinical, and laboratory data were collected using a standardized case

251 Upon admission, clinical and laboratory data were collected, King's College Criteria

252 Survey, anthropometric measurements, and laboratory data were collected.

253 Demographic, clinical, and laboratory data were collected.

254 Clinical and laboratory data were collected.

255 Clinical and laboratory data were collected.

256 Demographic, clinical, and laboratory data were collected.

257 Demographic and baseline laboratory data were comparable.

258 Demographic, clinical, and laboratory data were compared to identify risk factors f

259 Clinical, histologic, and laboratory data were compared using nonparametric statis

260 Their epidemiological, clinical, and laboratory data were extracted and stratified by month,

261 Vital sign, demographic, location, and laboratory data were extracted from the electronic healt

262 Participant characteristics and laboratory data were extracted.

263 Clinical and laboratory data were gathered on 10,750 previously untre

264 After 1 year, her symptoms and her laboratory data were improved.

265 n, 6.3 per patient) and 38.9% of all audited laboratory data were inaccurately communicated.

266 Clinical and laboratory data were linked for all patients presenting

267 Computerized pharmacy, hospital, and laboratory data were linked to survey data for analysis.

268 Individual clinical, pharmacy, and laboratory data were merged using individual hospital id

269 Clinical and laboratory data were obtained from 696 patients with CID

270 Clinical and laboratory data were obtained from the patient records a

271 ultrasound examination was performed and the laboratory data were obtained.

272 Clinical and laboratory data were obtained.

273 and questionnaire follow-up of clinical and laboratory data were performed on patients with intermed

274 erioperative, and postoperative clinical and laboratory data were prospectively collected and compare

275 Clinical and laboratory data were recorded for every patient.

276 nths and for whom comprehensive clinical and laboratory data were recorded prospectively; data were a

277 Basic demographic and laboratory data were recorded.

278 Physiologic and laboratory data were recorded.

279 Clinical and laboratory data were retrieved from medical records to i

280 wo-plane radiographs, clinical findings, and laboratory data were reviewed in 13 children (median age

281 Clinical and laboratory data were reviewed.

282 nd sleep apnea, and changes in corresponding laboratory data were studied.

283 The rest of the laboratory data were unremarkable.

284 Additional laboratory data were used to track cases.

285 including the corresponding radiographs and laboratory data, were prospectively reviewed by one of t

286 Correlations of clinical and laboratory data with urinary and serum levels of lipocal

287 e extensively investigated with clinical and laboratory data, with a follow-up of at least 18 months.